Glenmark s post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19 aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Glenmark Lifesciences shares will be allotted today Check the Status with This Process jagran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagran.com Daily Mail and Mail on Sunday newspapers.
Subscribe
Although product concentration remains a key risk where top 10 products contribute 66.36%, the company aims to reduce the dependence with planned capex in FY22, said a report by GEPL Capital Research. “We recommend a subscribe rating to the issue, considering strong research and development (R&D) capabilities, clean regulatory history, strong promoter backing with synergies and planned capex to drive medium term growth,” the report added.
Advertisement
Moreover, the company is benefiting from an anti-China product strategy going around the globe.
“Except for one antimalarial product segment, our demand outlook, I mean demand that we are getting from customers from the last five quarters has been extremely solid. See, no one is saying that we are buying less from China and more from India, but it is very clear to see that kind of demand. So I believe China Plus One is a real thing,” said Yasir Rajwee, chief executive officer (CEO) of Glenmark Life Sciences in an
Animal health API Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2027
marcusMay 5, 2021
The market research report titled ”
Animal health API Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2027 “ published by MR Accuracy Reports provides an insightful comprehension about the growth aspects, dynamics, and working of the global
Animal health API Market. The report entails details about the market with data collected over the years with its wide-ranging analysis. It also comprises the competitive landscape within the market together with a detailed evaluation of the leading players within the global Animal health API Market. In addition, it sheds light on the profiles of the key vendors/manufacturers comprising thorough assessment of the market share, production technology, market entry strategies, revenue forecasts, and so on. Further, the report will encompass the fundamental strategic activities such a
CAGR of 10.1% during the forecast period (2018-2026).
Market Analysis:
Rampant development of liquid ursodeoxycholic acid has offered ample growth opportunities to the companies operating in the global ursodeoxycholic acid market in the recent past. With the introduction of liquid formulations of ursodeoxycholic acid, healthcare professionals are now able to prescribe an alternate dosing method to patients who have difficulty in swallowing tablets or capsules. Extensive R&D of ursodeoxycholic acid, along with a high prevalence of diseases like gallstone and liver cirrhosis, has majorly boosted the global ursodeoxycholic acid market development.
To learn more about this report, request a sample copy